Senior Director, Global Launch Lead – empasiprubart in MMN

Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.

We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients. 

Join argenx 

argenx is a global immunology company dedicated to developing innovative therapies that improve the lives of people with severe autoimmune diseases. With teams across Boston, Ghent, Japan, Canada, Europe, and Emerging Markets, we are united by our values: co-creation, empowerment, humility, innovation, and excellence. 

Our science-based, data-driven, and patient-focused approach has led to groundbreaking initiatives like MG United, MyRealWorld MG, and the Cannes Bronze Lion-winning docuseries A Mystery to Me. As we expand our therapeutic franchises—including neuromuscular, hematology, dermatology, and nephrology—we remain committed to listening to the communities we serve and integrating their goals into our work. 

The Opportunity 

We are seeking a strategic and visionary Senior Director, Global Launch Lead to lead the global launch of empasiprubart in Multifocal Motor Neuropathy (MMN), currently in Phase 3. This is a high-impact role that will shape the global launch strategy, drive cross-functional execution, and ensure market readiness for a therapy poised to transform the MMN treatment landscape. 

You will be a key member of the Global Commercialization community and Chair of the MMN Indication Commercialization Team (ICT), collaborating across geographies and disciplines to deliver an integrated launch plan that maximizes the value of empasiprubart. 

At argenx, you’ll be part of a purpose-driven organization that values innovation, collaboration, and patient impact. You’ll have the opportunity to lead a global launch that could redefine treatment for MMN and contribute to a legacy of scientific excellence and community-first healthcare. 

Key Responsibilities 

• Develop and lead the global launch strategy for empasiprubart in MMN, aligned with argenx Vision 2030 

• Drive launch readiness across functions including Medical Affairs, Market Access, Regulatory, Patient Advocacy, HEOR, CMC, Scientific Communications, and Commercial Operations 

• Oversee brand creation and positioning for empasiprubart 

• Define and monitor launch KPIs, adjusting strategies to ensure success 

• Chair the ICT and serve as the central point of contact for global launch activities 

• Build and manage relationships with external stakeholders (HCPs, KOLs, advocacy groups, regulators) 

• Ensure compliance with global regulatory and ethical standards 

• Lead budget planning and resource allocation for launch activities 

• Conduct market analysis, competitive intelligence, and scenario planning to inform strategic decisions 

Qualifications 

• Advanced degree (MBA, PhD, PharmD, or MD) preferred 

• 12+ years of commercial experience in pharma/biotech, including marketing and sales 

• Proven success launching rare disea